Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Corynebacterium pseudodiphtheriticum Exploits Staphylococcus aureus Virulence Components in a Novel Polymicrobial Defense Strategy.

Hardy BL, Dickey SW, Plaut RD, Riggins DP, Stibitz S, Otto M, Merrell DS.

MBio. 2019 Jan 8;10(1). pii: e02491-18. doi: 10.1128/mBio.02491-18.

2.

Staphylococcus aureus Epicutaneous Exposure Drives Skin Inflammation via IL-36-Mediated T Cell Responses.

Liu H, Archer NK, Dillen CA, Wang Y, Ashbaugh AG, Ortines RV, Kao T, Lee SK, Cai SS, Miller RJ, Marchitto MC, Zhang E, Riggins DP, Plaut RD, Stibitz S, Geha RS, Miller LS.

Cell Host Microbe. 2017 Nov 8;22(5):653-666.e5. doi: 10.1016/j.chom.2017.10.006.

3.

Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus-positive patients.

Riggins DP, Cunningham CO, Ning Y, Fox AD.

Subst Abus. 2017 Jul-Sep;38(3):297-302. doi: 10.1080/08897077.2016.1220443. Epub 2016 Aug 11.

4.

Escherichia coli K-12 survives anaerobic exposure at pH 2 without RpoS, Gad, or hydrogenases, but shows sensitivity to autoclaved broth products.

Riggins DP, Narvaez MJ, Martinez KA, Harden MM, Slonczewski JL.

PLoS One. 2013;8(3):e56796. doi: 10.1371/journal.pone.0056796. Epub 2013 Mar 8.

5.

Hydrogenase-3 contributes to anaerobic acid resistance of Escherichia coli.

Noguchi K, Riggins DP, Eldahan KC, Kitko RD, Slonczewski JL.

PLoS One. 2010 Apr 12;5(4):e10132. doi: 10.1371/journal.pone.0010132.

Supplemental Content

Loading ...
Support Center